Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24524N0411
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $12,559.90 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg-30mg on March 8, 2024, with an ultimate completion date of March 15, 2024. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. This delivery order was issued without a set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), reflecting standard competitive procurement procedures for established pharmaceutical manufacturers.
This award represents a task order against Otsuka America Pharmaceutical Inc.'s larger $83.3 million Blanket Purchase Agreement with the VA's National Acquisition Center, which carries an ultimate completion date of March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently procure Jynarque and supports the VA's mission of delivering specialized pharmaceutical treatments to veterans nationwide. Otsuka America maintains an established federal contracting relationship with the VA, supported by a broader $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, positioning the company as a key supplier of complex specialty medications to the federal healthcare system.
Quick answers
Who was awarded contract 36C24524N0411?
36C24524N0411 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 8, 2024.
How much is contract 36C24524N0411 worth?
The government has obligated $12,560 on 36C24524N0411.
Is contract 36C24524N0411 an order under another contract?
Yes. 36C24524N0411 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0411 competed?
The extent of competition for 36C24524N0411 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award